Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis

Volume: 18, Issue: 1, Pages: 73 - 87
Published: Jan 1, 2022
Abstract
Transthyretin cardiac amyloidosis (ATTR-CA) is a systemic disorder resulting from the extracellular deposition of amyloid fibrils of misfolded transthyretin protein in the heart. ATTR-CA is a life-threatening disease, which can be caused by progressive deposition of wild type transthyretin (wtATTR) or by aggregation of an inherited mutated variant of transthyretin (mATTR). mATTR Is a rare condition transmitted in an autosomal dominant manner...
Paper Details
Title
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis
Published Date
Jan 1, 2022
Volume
18
Issue
1
Pages
73 - 87
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.